Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from cancer and type 2 diabetes to asthma.
Ozempic Among 15 New Drugs Up For Price Negotiations
Ozempic, the popular diabetes drug widely used for weight loss, was among the 15 prescription drugs selected for Medicare price negotiations announced by President Joe Biden's administration on Friday (January 17),
Biden administration adds 15 drugs to Medicare price negotiation list
The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration and, if deals are reached, almost assure billions of dollars in savings for taxpayers.
Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
15 New Drugs Selected for Medicare Price Negotiations
The bad news is people on Medicare will have to wait a while before they see the savings. Retirees could feel the economic impact of President-elect Donald Trump prepares to reclaim office in Washington,
Medscape2d
ISMP Updates its List of Drug Name Pairs with TALL Man Letters
Resources used to select the drug name pairs targeted for tall man letters included the ISMP list of name pairs with recommended tall man letters (63%), the FDA-approved list of name pairs with ...
BioSpace9d
Part D Drugs Almost Doubled in Cost Since Launch, Underscoring Importance of IRA: AARP
Concurrently, a preprint from the industry-backed Vital Transformation found a 50% drop in company investments into ...